174 related articles for article (PubMed ID: 17410551)
1. Determination of ruthenium originating from the investigational anti-cancer drug NAMI-A in human plasma ultrafiltrate, plasma, and urine by inductively coupled plasma mass spectrometry.
Brouwers EE; Tibben MM; Rosing H; Schellens JH; Beijnen JH
Rapid Commun Mass Spectrom; 2007; 21(9):1521-30. PubMed ID: 17410551
[TBL] [Abstract][Full Text] [Related]
2. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
[TBL] [Abstract][Full Text] [Related]
3. Validated method for the determination of the novel organo-ruthenium anticancer drug NAMI-A in human biological fluids by Zeeman atomic absorption spectrometry.
Crul M; van den Bongard HJ; Tibben MM; van Tellingen O; Sava G; Schellens JH; Beijnen JH
Fresenius J Anal Chem; 2001 Mar; 369(5):442-5. PubMed ID: 11270226
[TBL] [Abstract][Full Text] [Related]
4. Determination of platinum originating from carboplatin in canine sebum and cerumen by inductively coupled plasma mass spectrometry.
Janssens T; Brouwers EE; de Vos JP; Schellens JH; Beijnen JH
J Pharm Biomed Anal; 2011 Jan; 54(2):395-400. PubMed ID: 20933356
[TBL] [Abstract][Full Text] [Related]
5. Fate of the antimetastatic ruthenium complex ImH [trans-RuCl4(DMSO)Im] after acute i.v. treatment in mice.
Cocchietto M; Salerno G; Alessio E; Mestroni G; Sava G
Anticancer Res; 2000; 20(1A):197-202. PubMed ID: 10769655
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of an inductively coupled plasma mass spectrometry method with optimized microwave-assisted sample digestion for the determination of platinum at ultratrace levels in plasma and ultrafiltrate plasma.
Breda M; Maffini M; Mangia A; Mucchino C; Musci M
J Pharm Biomed Anal; 2008 Sep; 48(2):435-9. PubMed ID: 18508222
[TBL] [Abstract][Full Text] [Related]
7. Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin.
Groessl M; Zava O; Dyson PJ
Metallomics; 2011 Jun; 3(6):591-9. PubMed ID: 21399784
[TBL] [Abstract][Full Text] [Related]
8. The role of cisplatin and NAMI-A plasma-protein interactions in relation to combination therapy.
Khalaila I; Bergamo A; Bussy F; Sava G; Dyson PJ
Int J Oncol; 2006 Jul; 29(1):261-8. PubMed ID: 16773208
[TBL] [Abstract][Full Text] [Related]
9. Blood levels of ruthenium following repeated treatments with the antimetastatic compound NAMI-A in healthy beagle dogs.
Sava G; Cocchietto M
In Vivo; 2000; 14(6):741-4. PubMed ID: 11204491
[TBL] [Abstract][Full Text] [Related]
10. A liquid chromatography-mass spectrometry assay for simultaneous determination of two antimalarial thiazolium compounds in human and rat matrices.
Taudon N; Margout D; Calas M; Kezutyte T; Vial HJ; Bressolle FM
J Pharm Biomed Anal; 2008 Nov; 48(3):1001-5. PubMed ID: 18678456
[TBL] [Abstract][Full Text] [Related]
11. Determination of oxaliplatin in human plasma and plasma ultrafiltrate by graphite-furnace atomic-absorption spectrometry.
Brouwers EE; Tibben MM; Joerger M; van Tellingen O; Rosing H; Schellens JH; Beijnen JH
Anal Bioanal Chem; 2005 Aug; 382(7):1484-90. PubMed ID: 15952001
[TBL] [Abstract][Full Text] [Related]
12. Determination of platinum originating from carboplatin in human urine and canine excretion products by inductively coupled plasma mass spectrometry.
Janssens T; Brouwers EE; de Vos JP; Schellens JH; Beijnen JH
J Anal Toxicol; 2011 Apr; 35(3):153-61. PubMed ID: 21439151
[TBL] [Abstract][Full Text] [Related]
13. Validated assay for the simultaneous quantification of total vincristine and actinomycin-D concentrations in human EDTA plasma and of vincristine concentrations in human plasma ultrafiltrate by high-performance liquid chromatography coupled with tandem mass spectrometry.
Damen CW; Israëls T; Caron HN; Schellens JH; Rosing H; Beijnen JH
Rapid Commun Mass Spectrom; 2009 Mar; 23(6):763-74. PubMed ID: 19204931
[TBL] [Abstract][Full Text] [Related]
14. Tumour cell uptake G2-M accumulation and cytotoxicity of NAMI-A on TS/A adenocarcinoma cells.
Bergamo A; Zorzet S; Cocchietto M; Carotenuto ME; Magnarin M; Sava G
Anticancer Res; 2001; 21(3B):1893-8. PubMed ID: 11497274
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of the organic ruthenium anticancer drug Nami-A is correlated with DNA binding in four different human tumor cell lines.
Pluim D; van Waardenburg RC; Beijnen JH; Schellens JH
Cancer Chemother Pharmacol; 2004 Jul; 54(1):71-8. PubMed ID: 15034754
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine.
Lindegårdh N; Hanpithakpong W; Wattanagoon Y; Singhasivanon P; White NJ; Day NP
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(1):74-83. PubMed ID: 17913596
[TBL] [Abstract][Full Text] [Related]
17. Quantitative determination of icotinib in human plasma and urine using liquid chromatography coupled to tandem mass spectrometry.
Liu D; Jiang J; Hu P; Tan F; Wang Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(30):3781-6. PubMed ID: 19833564
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a liquid chromatographic/mass spectrometry method for quantification of tetrandrine in rat plasma and its application to pharmacokinetic study.
Song N; Zhang S; Li Q; Liu C
J Pharm Biomed Anal; 2008 Nov; 48(3):974-9. PubMed ID: 18650047
[TBL] [Abstract][Full Text] [Related]
19. Capillary electrophoresis hyphenated to inductively coupled plasma-mass spectrometry: a novel approach for the analysis of anticancer metallodrugs in human serum and plasma.
Groessl M; Hartinger CG; Polec-Pawlak K; Jarosz M; Keppler BK
Electrophoresis; 2008 May; 29(10):2224-32. PubMed ID: 18512673
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activity.
Groessl M; Reisner E; Hartinger CG; Eichinger R; Semenova O; Timerbaev AR; Jakupec MA; Arion VB; Keppler BK
J Med Chem; 2007 May; 50(9):2185-93. PubMed ID: 17402720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
